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ABSTRACT
Advisors: Dr. Kathleen Hughes and Dr. Lauren King

We studied the effects of ethynodiol diacetate on the viability of hydrogen
peroxide stressed glial cells. We wanted to determine the extent in which varying concentration of
ethynodiol diacetate affect cell viability of cultured glial cells from hydrogen peroxide toxicity.
Based on previous studies, we predicted that the viability of hydrogen peroxide-stressed cells will
increase with the presence of the progesterone, ethynodiol diacetate, and that cell viability will
increase with increasing concentration of ethynodiol diacetate. Glial cells of 1x10° cells/well were
introduced into a 96-well plate and allowed to grow for 24 hours in an incubator at 37°C and 5%
COs. Cells were treated with 0 nM (control), 10 nM, 100 nM, 1 uM, 10 uM ethynodiol diacetate
in doublets, with half of the cells being stressed with hydrogen peroxide. Data were analyzed
using a 2-way ANOVA and a Tukey’s post hoc test with a p-value of less than 0.05 being
significant. Viability did not differ significantly between stressed and unstressed cells (2-way
ANOVA, Fo30=1.673, P=0.211) or between cells receiving varying concentrations of ethynodiol
diacetate (2-way ANOVA, Fo30=0.638 P=0.641). The results illustrate that ethynodiol diacetate,
when under these treatment parameters, does not have protective effects on the glial cell cultures.
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INTRODUCTION

The Involvement of Progesterone in Glial Cell Viability
Background
Hormonal birth control is a form of female contraception. Around sixty percent of
women who utilize contraception currently use a non-permanent method, such as hormonal birth
control (Daughery et al. 2014). Common hormonal methods include the birth control pill, patch,
and vaginal ring (Daughery etal. and Jones et al., 2014, 2012) and usually contain varying
amounts of steroid hormones including estrogens and progesterones. When consumed, estrogen
and progesterone send a signal to the brain which causes a range of effects within the body
including preventing ovulation, stopping production of the luteinizing hormone (LH), and
stopping the pituitary gland from secreting the follicle-stimulating hormone (FSH) (Nichols,
2018). One role of progesterone and estrogen is assisting in the prevention of the secretion of
gonadotropins (FSH and LH) through a negative feedback mechanism (Shaw et al., 2010).
Progesterone is derived from the placenta and/or the corpus luteum and has been shown
to play an essential role in the stimulation of the uterus in preparation for pregnancy (Siiteri et
al., 1977). It prevents ovulation and thickens the cervical mucus. Some adverse side effects
caused by hormonal birth control include weight gain, changes in or the absence of a menstrual
cycle, mood changes, and the worsening of migraines. With high levels of progesterone
specifically, side effects include stomach problems, premenstrual syndrome (PMS)-like
symptoms, irregular bleeding, breast discomfort or enlargement, and depression (Childs, 2018).
The progesterone of interest in my study is ethynodiol diacetate. This progesterone is
used to help prevent pregnancy by thickening the mucus within the vagina, which in turn

prevents the sperm from penetrating the egg. Ethynodiol diacetate is a synthetic form of the
naturally-occurring female sex hormone, progesterone (Briggs, 1975). Ethynodiol diacetate has a
molecular weight of 384.5 g/mol and a chemical formula of C24H3,04. During the menstrual
cycle an ovum is released from the ovary through a process known as ovulation. Following
ovulation, the follicle that released the ovum becomes known as the corpus luteum. The corpus
luteum produces progesterone which prevents the further release of eggs. Progesterone also
prepares the lining of the uterus for possible pregnancies that may occur. When pregnancy
occurs the progesterone levels remain high, and if no pregnancy occurs the levels drop resulting
in a menstrual period. Ethynodiol diacetate prevents the release of additional ova from the
ovaries, thus preventing pregnancy (Briggs, 1975). Progesterone affects brain physiology
through three principle mechanisms: regulation of gene expression, modulation of
neurotransmitter systems, and activation of signaling cascades (Brinton, D.R., et al., 2008).
The mechanism of ethynodiol diacetate involves binding to progesterone and estrogen receptors.
Cells expressing these receptors are found in the female reproductive tract, mammary gland, the
hypothalamus, and the pituitary. Upon binding to the receptor, the ethynodiol diacetate will slow
the frequency of the release of gonadotropin releasing hormone (GnHR) from the hypothalamus
and slow the preovulatory luteinizing hormone (LH) surge (Briggs, 1975). Ethynodiol diacetate
is a first-generation progesterone of average progestational activity. It has minor estrogenic
effects and little androgenic activity (Progestin, 2018). Ethynodiol diacetate is a derivative of
norethindrone, another type of progesterone.
Astrocytes are a form of glial cells, which are predominantly found in the spinal cord and
brain. These cells play a role in the formation of the blood-brain barrier, as well as serving as
supportive cells for neurons. One function to note is that the astrocytes within the hypothalamus

play a role in the central nervous system through the regulation of hormones, particularly female
hormones (Micevych, et al., 2010). When ovulation occurs, the hypothalamus releases the
gonadotropin releasing hormone (GnRH); this in turn triggers an increase in luteinizing hormone
(LH) which triggers ovulation (Micevych et al., 2010)
Recent studies have illustrated that progesterone plays a role in multiple non-reproductive
functions in the central nervous system. These functions include the regulation of mood,
cognition, mitochondrial function, neurogenesis and regeneration, myelination, and recovery

from traumatic brain injury (Brinton et al., 2008). One study indicated that when progesterone
was delivered to a patient after a brain injury, it caused a decrease in the cytotoxic responses as
well as promoting functional recovery (Grossman, et al., 2004).

Brain injuries create an

inflammatory response by disturbing the blood brain barrier, which in turn causes edema and the
permeation of inflammatory cells (Carlos et al., 1997). Progesterone also plays a role in
diminishing neurological abnormalities after ischemia (Chen et al., 1999) and spinal cord injuries
(Thomas et al., 1999), as well as the reduction of neuronal cell death (Cervantes et al., 2001).
Hydrogen peroxide is a byproduct of respiration that, when in excessive quantities, can
lead to cellular damage caused by oxidative stress. One study showed that hydrogen peroxide
alters astrocyte membrane and cytoskeleton through damaging lipids, proteins, DNA, and
through signaling molecules which cause the intracellular pathways to cause apoptosis (Choi et

al., 2007).
Despite advances in hormonal knowledge, not much is known about the effects
progesterones have on the viability of astrocytes directly. Therefore, the goal of this study was to
determine the effect progesterones have on the viability of hydrogen peroxide-stressed
astrocytes. I hypothesized that the viability of hydrogen peroxide-stressed cells will increase with

the presence of the progesterone, ethynodiol diacetate, and that as the concentration of
ethynodiol diacetate increases, so will cell viability.

METHODS

Cells
The cell line used in this study were 1321N1, which were cultured human glioma cells
with astrocyte-like properties (Sigma Aldrich). The cells were plated in a T-75 flask with 10 ml
media, which consisted of Dulbecco's Modified Eagle's Medium supplemented with 10% fetal
bovine serum and 1% penicillin/streptomycin. The media in the well plate was replaced every
two to three days. The astrocytes were stored and incubated at 37°C with 5% supplemented CO».
Once the cells became roughly 70-80% confluent in the flask, the existing media was
removed and a 5 mL solution containing 0.53 mM EDTA and 25% trypsin was added to rinse the
flask. The trypsin-EDTA solution helped remove the adherent cells from the flask’s surface.
Once the cells were removed from the surface, the suspension was placed into a tube and
centrifuged at 3000 x rpm for 3 minutes in order to pellet the cells. The supernatant containing
trypsin was then removed and discarded, leaving behind the cell pellet which was resuspended in
5 mL fresh media. This solution was then plated into a 96-well plate. Each well contained 200
uL of media with a concentration of about 1x10° cells/mL (Grimes and Hughes, 2015). An
automated BioRad cell counter was used in order to determine the concentration of cells in the
wells. A solution of 100 pL of prepared astrocytes with an equal amount of trypan blue solution
was prepared in one of the wells in the 96-well plate, which allowed for the determination of
total and live cell count. A 10 pL. amount of the trypan blue and glial cell solution was added to
the slide using a micropipette, which was then inserted into the counter where the live and total
counts were determined. The number of cells counted was used to help calculate the amount of
cell suspension and media needed to dilute the concentration to 1x10° cells/mL. Once the volume
of cell suspension was calculated, it was then subtracted from the total amount of media that
would be added into the cell suspension. A 200 pL cell and media solution was then added to

each well and then placed back into the incubator. After these steps, treatment began the
following day.

Treatment of Astrocytes

To test the effects of progesterone on glial cell viability, cultures treated with varying
concentrations of ethynodiol diacetate (0 nM (control), 10 nM, 100 nM, 1 pM, 10 uM) were
tested for viability. The ethynodiol diacetate was diluted to the appropriate concentration using
phosphate buffered saline. The independent variables measured were ethynodiol diacetate
treatment (at varying concentrations) and whether or not the cells were stressed with hydrogen
peroxide. The control wells received phosphate buffered saline in volumes equal to that of the
treatments. The cells were incubated at 37°C for one hour. Half of the wells were then treated
with 5 pL of a 40 mM hydrogen peroxide solution for one hour. Following stress treatment,
media was replaced in each well with 200 pL of fresh media supplemented with the appropriate
ethynodiol diacetate concentration. Viability was then measured after incubating for 24 hours.
Three trials were completed with the above steps. The 96-well plate used is diagrammed below.
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Figure 1. The 96-well plate treatment diagram. The cells in rows A and B were first treated with the progesterone,
Ethynodiol diacetate with the concentrations, 0 uM, 10 uM, 1 pM, 1 nM, and 10 nM and 100 nM, in wells 0, 2, 4, 6,
8, and 10, respectively. All the cells in row A were stressed with 5 pL. of a 40 mM hydrogen peroxide solution, with
all the cells in row C receiving no hydrogen peroxide. After one hour hydrogen peroxide was added and the cells
were stressed for an hour. The solutions were then changed and replaced with 200 pL of media and the respective
ethynodiol diacetate concentrations. Ethynodiol diacetate (P): Hydrogen Peroxide (H,0,): with (-) and (+) indicating
the presence or absence of the variable.

MTT Cell Proliferation Assay
Following treatment, cell viability was assessed using the MTT Cell Proliferation Assay
from Sigma Aldrich. This was done by removing 100 pl of the media and adding 10 pl of the
MTT reagent to each well, followed by incubation at 37°C for three hours. One 100 pl of media
containing no cells was added to a well to serve as a blank for comparison. Once the precipitate
formed, 100 pl of the MTT solubilization solution was then added to the wells, and the
absorbance was taken at 570 nm. A high absorbance indicated a high cell proliferation.

Analysis of data
To evaluate the 3 trials performed and to determine statistical significance between the
two treatments, a 2-way Analysis of Variance (ANOVA) was used with a p-value of significance
being less than 0.05 along with a Tukey’s post hoc test.
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RESULTS
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Absorbance values were obtained from the MTT Assay. From the MTT assay results, a
ratio was determined between the treated cells and the control by subtracting the absorbance of
the blank and then dividing by the control; the results were then averaged and plotted. Viability
did not differ significantly between stressed and unstressed cells (2-way ANOVA, F930=1.673,
P=0.211) or between cells receiving varying concentrations of ethynodiol diacetate (2-way
ANOVA, F930=0.638 P=0.641). This is seen in Figure 1, which compares the results of the
stressed versus unstressed astrocyte cells as well as the varying ethynodiol diacetate
concentrations.

il

i Hydrogen Peroxide (40 mM)

BB

3

OD (570 nm) Treatment/OD (570 nm)
Control

12

0

unstressed

0.01

Concentration of Siivdi
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Figure 1. Comparison of glial cell viability (+/- 1 S.D) for cells treated with 0 uM, 0.01 uM, 0.1
uM, 1 pM, and 10 pM Ethynodiol diacetate that were either stressed with 5 pLfof a 40mM

hydrogen

peroxide solution or unstressed. Results were not significant between the stressed and unstressed data
(2-way ANOVA, F , =1.673, P=0.211) and between the varying concentration of Ethynodiol diacetate

(2-way ANOVA, F, =0.638 P=0.641).
The absorbance values compared to control are reported for each concentration and
between stressed and unstressed are listed as average ratios (+/- standard error). The average
ratio of the cells treated with 0 pM ethynodiol diacetate and stressed with hydrogen peroxide was
0.797 (+/- 0.1517). The average absorbance ratio of the cells treated with 0.01 uM ethynodiol
diacetate and stressed with hydrogen peroxide was 0.185 (+/- 0.1261) and unstressed was 1.014
(+/- 0.4270). The average absorbance ratio of the cells treated with 0.1 uM ethynodiol diacetate
and stressed with hydrogen peroxide was 0.8486 (+/- 0.2025) and unstressed was 0.3818 (+/0.0320). The average absorbance ratio of the cells treated with 1 pM ethynodiol diacetate and

13

stressed with hydrogen peroxide was 0.4167 (+/- 0.2140) and unstressed was 0.8378 (+/-0.3408).
The average absorbance ratio of the cells treated with 10 uM ethynodiol diacetate and stressed
with hydrogen peroxide was 0.8087 (+/- 0.3002) and unstressed was 0.7907 (+/- 0.2120).
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DISCUSSION
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Treatment with ethynodiol diacetate and with hydrogen peroxide showed no significant
difference in glial cell viability when compared to the unstressed control. The results did not
support the hypothesis that the viability of hydrogen peroxide-stressed cells would increase with
the pretreatment of ethynodiol diacetate. A previous study indicated that when progesterone was
delivered to a patient after a brain injury, it caused a decrease in the cytotoxic responses as well
as promoting functional recovery (Grossman, et al., 2004). Another study done by Cervantes et
al., (2001) showed that progesterone played a role in the reduction of neuronal cell death. In my
study, however, ethynodiol diacetate did not provide any protection to the glial cells against the
hydrogen peroxide stressor. The concentrations used in this study, 0 uM, 0.01 uM, 0.1 pM, 1 pM
and 10 uM, may have been too low to induce any protective effects towards the glial cells.
Higher concentrations, though, would not be analogous to in vivo levels. For example, the in vivo
blood concentration of ethynodiol diacetate from consuming oral hormonal contraceptives is
0.31 uM. In addition to concentrations, the glial cells were not properly adhering to the wells and
were removed during trials, thus possibly skewing the data as both live and dead cells were being
removed. This observation could be indicative of the cells either being unhealthy prior to
treatment or requiring a longer incubation time to adhere to the wells.
One study showed that hydrogen peroxide alters astrocyte membrane and cytoskeleton
through damaging lipids, proteins, DNA, and through signaling molecules which cause the
intracellular pathways to cause apoptosis (Choi et al., 2007). The treatment of cells with

16

hydrogen peroxide appeared to causes a decrease in cell viability, but cannot be concluded
without doing further tests to determine the oxidative stress caused by hydrogen peroxide to glial
cells. Thus, future studies could look at directly measuring the oxidative stress hydrogen
peroxide imposes on the cells.
This study was limited to three trials due to time constraints and contamination to the
glial cells. Data was limited when concerning the effects of progesterone on glial cell viability,
due to most research being centered towards the effects progesterone has on reproductive
functions and not how they affect glial cells. Therefore, it became difficult to determine adequate
concentrations and exposure time for ethynodiol diacetate. Thus, it is possible that ethynodiol
diacetate did not have enough time to exert effects on the glial cells.
The ability to better understand the effects of ethynodiol diacetate, a main progesterone
used in hormonal contraceptives, on astrocytes will aid in the understanding of its role in
neurochemistry.
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